Literature DB >> 29883626

Metabolism and epilepsy: Ketogenic diets as a homeostatic link.

Susan A Masino1, Jong M Rho2.   

Abstract

Metabolic dysfunction can underlie seizure disorders, and metabolism-based treatments can afford seizure control and promote homeostasis. This relationship between metabolism and the risk of sporadic seizures was observed historically with the clinical success of a low-carbohydrate, high-fat, ketosis-inducing ketogenic diet - a treatment that remains relevant today, and one that has been shown to be effective against medically refractory epilepsy. Mechanisms underlying the success of the ketogenic diet are a topic of intense research efforts - not only because of proven success in arresting treatment-resistant seizures, but also because recent evidence suggests that altering metabolism with a ketogenic diet enables a homeostatic state in the brain that is less excitable, and hence raises the threshold for seizure genesis. Metabolic therapy with a ketogenic diet has been shown to normalize a range of abnormal physiological and behavioral parameters and may also make the central nervous system more resilient to other insults or physiological stresses. Because the therapeutic ability of such a diet may be more limited than a drug because of a dose "ceiling", investigations are underway to develop and test analogous or supplemental approaches. In addition, significant efforts have been made to demonstrate broader applications of metabolic therapy in promoting health and preventing disease, including conditions where epileptic seizures manifest in a comorbid fashion.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Epilepsy; Homeostasis; Ketogenic diet; Ketosis; Metabolism; Seizures

Mesh:

Year:  2018        PMID: 29883626      PMCID: PMC6281876          DOI: 10.1016/j.brainres.2018.05.049

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  68 in total

Review 1.  New insights into the mechanisms of the ketogenic diet.

Authors:  Detlev Boison
Journal:  Curr Opin Neurol       Date:  2017-04       Impact factor: 5.710

2.  What are the minimum requirements for ketogenic diet services in resource-limited regions? Recommendations from the International League Against Epilepsy Task Force for Dietary Therapy.

Authors:  Eric H Kossoff; Nabil Al-Macki; Mackenzie C Cervenka; Heung D Kim; Jianxiang Liao; Katherine Megaw; Janak K Nathan; Ximena Raimann; Rocio Rivera; Adelheid Wiemer-Kruel; Emma Williams; Beth A Zupec-Kania
Journal:  Epilepsia       Date:  2015-05-29       Impact factor: 5.864

3.  Ketonemia and seizures: metabolic and anticonvulsant effects of two ketogenic diets in childhood epilepsy.

Authors:  P R Huttenlocher
Journal:  Pediatr Res       Date:  1976-05       Impact factor: 3.756

4.  A ketogenic diet suppresses seizures in mice through adenosine A₁ receptors.

Authors:  Susan A Masino; Tianfu Li; Panos Theofilas; Ursula S Sandau; David N Ruskin; Bertil B Fredholm; Jonathan D Geiger; Eleonora Aronica; Detlev Boison
Journal:  J Clin Invest       Date:  2011-06-23       Impact factor: 14.808

5.  Long-term follow-up of the ketogenic diet for refractory epilepsy: multicenter Argentinean experience in 216 pediatric patients.

Authors:  Roberto Caraballo; María Vaccarezza; Ricardo Cersósimo; Viviana Rios; Alejandra Soraru; Hugo Arroyo; Guillermo Agosta; Nidia Escobal; Martha Demartini; Clarisa Maxit; Araceli Cresta; Delfina Marchione; María Carniello; Luis Paníco
Journal:  Seizure       Date:  2011-07-16       Impact factor: 3.184

6.  Metabolic autocrine regulation of neurons involves cooperation among pannexin hemichannels, adenosine receptors, and KATP channels.

Authors:  Masahito Kawamura; David N Ruskin; Susan A Masino
Journal:  J Neurosci       Date:  2010-03-17       Impact factor: 6.167

7.  The ketogenic diet inhibits epileptogenesis in EL mice: a genetic model for idiopathic epilepsy.

Authors:  M T Todorova; P Tandon; R A Madore; C E Stafstrom; T N Seyfried
Journal:  Epilepsia       Date:  2000-08       Impact factor: 5.864

8.  A modified Atkins diet is effective for the treatment of intractable pediatric epilepsy.

Authors:  Eric H Kossoff; Jane R McGrogan; Renee M Bluml; Diana J Pillas; James E Rubenstein; Eileen P Vining
Journal:  Epilepsia       Date:  2006-02       Impact factor: 5.864

9.  Elevated polyunsaturated fatty acids in blood serum obtained from children on the ketogenic diet.

Authors:  D D Fraser; S Whiting; R D Andrew; E A Macdonald; K Musa-Veloso; S C Cunnane
Journal:  Neurology       Date:  2003-03-25       Impact factor: 9.910

10.  Ketogenic diet improves core symptoms of autism in BTBR mice.

Authors:  David N Ruskin; Julia Svedova; Jessica L Cote; Ursula Sandau; Jong M Rho; Masahito Kawamura; Detlev Boison; Susan A Masino
Journal:  PLoS One       Date:  2013-06-05       Impact factor: 3.240

View more
  11 in total

1.  Ketogenic diet and ketamine infusion treatment to target chronic persistent eating disorder psychopathology in anorexia nervosa: a pilot study.

Authors:  Lori Calabrese; Barbara Scolnick; Beth Zupec-Kania; Caroline Beckwith; Kayla Costello; Guido K W Frank
Journal:  Eat Weight Disord       Date:  2022-08-23       Impact factor: 3.008

2.  β-Hydroxybutyrate and Medium-Chain Fatty Acids are Metabolized by Different Cell Types in Mouse Cerebral Cortex Slices.

Authors:  Jens V Andersen; Emil W Westi; Elliott S Neal; Blanca I Aldana; Karin Borges
Journal:  Neurochem Res       Date:  2022-08-23       Impact factor: 4.414

Review 3.  Adenosine and Ketogenic Treatments.

Authors:  David N Ruskin; Masahito Kawamura; Susan A Masino
Journal:  J Caffeine Adenosine Res       Date:  2020-09-16

Review 4.  Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing.

Authors:  Stephen C Cunnane; Mark J Millan; Eugenia Trushina; Cecilie Morland; Alessandro Prigione; Gemma Casadesus; Zane B Andrews; M Flint Beal; Linda H Bergersen; Roberta D Brinton; Suzanne de la Monte; Anne Eckert; Jenni Harvey; Ross Jeggo; Jack H Jhamandas; Oliver Kann; Clothide Mannoury la Cour; William F Martin; Gilles Mithieux; Paula I Moreira; Michael P Murphy; Klaus-Armin Nave; Tal Nuriel; Stéphane H R Oliet; Frédéric Saudou; Mark P Mattson; Russell H Swerdlow
Journal:  Nat Rev Drug Discov       Date:  2020-07-24       Impact factor: 84.694

5.  Highlights From the Annual Meeting of the American Epilepsy Society 2018.

Authors:  Barbara C Jobst; Elinor Ben-Menachem; Kevin E Chapman; Aradia Fu; Alica Goldman; Lawrence J Hirsch; Lara E Jehi; Eric H Kossoff; Madona Plueger; Jong M Rho; Catherine A Schevon; Shlomo Shinnar; Michael R Sperling; Timothy A Simeone; Janelle L Wagner; Fred Lado
Journal:  Epilepsy Curr       Date:  2019-05-03       Impact factor: 7.500

6.  Randomized trial of add-on triheptanoin vs medium chain triglycerides in adults with refractory epilepsy.

Authors:  Karin Borges; Neha Kaul; Jack Germaine; Patrick Kwan; Terence J O'Brien
Journal:  Epilepsia Open       Date:  2019-02-22

7.  Epilepsy Benchmarks Area II: Prevent Epilepsy and Its Progression.

Authors:  Devin K Binder; Detlev Boison; Tore Eid; Wayne N Frankel; Ana Mingorance; Bret N Smith; Penny A Dacks; Vicky Whittemore; Annapurna Poduri
Journal:  Epilepsy Curr       Date:  2020-01-15       Impact factor: 7.500

Review 8.  Astrocytes as Guardians of Neuronal Excitability: Mechanisms Underlying Epileptogenesis.

Authors:  Quirijn P Verhoog; Linda Holtman; Eleonora Aronica; Erwin A van Vliet
Journal:  Front Neurol       Date:  2020-11-26       Impact factor: 4.003

9.  Efficacy of medium chain triglyceride oil dietary supplementation in reducing seizure frequency in dogs with idiopathic epilepsy without cluster seizures: a non-blinded, prospective clinical trial.

Authors:  Jenifer Molina; Clementine Jean-Philippe; Lisa Conboy; Sonia Añor; Cristian de la Fuente; Marcin Adam Wrzosek; Andrea Spycher; Eva Luchsinger; Bettina Wenger-Riggenbach; Patricia Montoliu; Gualtiero Gandini; Marika Menchetti; João Carlos Ribeiro; Artur Varejão; Antonio Ferreira; Brian Zanghi; Holger Andreas Volk
Journal:  Vet Rec       Date:  2020-06-12       Impact factor: 2.695

Review 10.  Dietary medium chain triglycerides for management of epilepsy: New data from human, dog, and rodent studies.

Authors:  Felicity Y Han; Lisa Conboy-Schmidt; Galena Rybachuk; Holger A Volk; Brian Zanghi; Yuanlong Pan; Karin Borges
Journal:  Epilepsia       Date:  2021-06-25       Impact factor: 5.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.